Share
Publications
1 - 1 of 1 publications
-
17 August 2004 /Prices and reimbursement
Treatment of blood clots with platelet function inhibitors
The rising expenses of platelet function inhibitors are caused by several factors. In general, the consumption of these medicinal products is increasing, which is due to the fact that, both in relative and absolute terms, more people start treatment with platelet function inhibitors.
